Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.08 |
---|---|
High | 3.08 |
Low | 3.08 |
Bid | 3.20 |
Offer | 3.31 |
Previous close | 3.08 |
Average volume | 391.20 |
---|---|
Shares outstanding | 303.93m |
Free float | 270.74m |
P/E (TTM) | 36.92 |
Market cap | 1.10bn USD |
EPS (TTM) | 0.098 USD |
Data delayed at least 15 minutes, as of Jul 09 2025 07:00 BST.
More ▼
- MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
- MannKind to Present at Upcoming Investor Conferences
- MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
- MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
- MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
- MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
- MannKind to Present at Upcoming Investor Conferences
- MannKind Expands Executive Leadership Team
- MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash
More ▼